Juniper Pharmaceuticals Inc (JNP.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|62||2015||Independence Chairman of the Board|
|54||2016||Chief Executive Officer, Director|
|43||2017||Senior Vice President, Finance, Chief Financial Officer, Treasurer and Secretary (Principal Financial and Accounting Officer)|
|44||2013||Chief Operating Officer, Director|
- BRIEF-Juniper Pharmaceuticals To Explore Strategic Alternatives
- BRIEF-Juniper Pharmaceuticals Announces Extension Of Supply Agreement For Crinone
- German stocks - Factors to watch on January 3
- BRIEF-Juniper Pharmaceuticals Outlines Strategic Priorities For 2018 And Reports Recent Portfolio Progress
- BRIEF-Juniper Pharmaceuticals reports third quarter results